Hualan
301207.SZHualan Biological Bacterin Inc. Price (301207.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
602,429,841
(0.4025)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Hualan Biological Bacterin Inc.Currency: CNY
| YEAR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
284,911,448.00
+0% |
802,738,151.00
+182% |
1,048,988,237.00
+31% |
2,426,328,945.00
+131% |
1,829,813,885.00
-25% |
1,825,640,965.00
0% |
2,410,428,457.00
+32% |
||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 87,853,968.00 | 126,873,132.00 | 161,005,995.00 | 257,939,198.00 | 220,760,728.00 | 217,451,485.00 | 287,097,741.00 | ||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
197,057,480.00
+0% |
675,865,019.00
+243% |
887,982,242.00
+31% |
2,168,389,747.00
+144% |
1,609,053,157.00
-26% |
1,608,189,480.00
0% |
2,123,330,716.00
+32% |
||||||||||||
| Gross Profit Ratio | (0.69%) | (0.84%) | (0.85%) | (0.89%) | (0.88%) | (0.88%) | (0.88%) | ||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 64,021,137.00 | 52,976,547.00 | 73,042,003.00 | 110,937,486.00 | 144,128,186.00 | 134,639,873.00 | 91,108,469.00 | ||||||||||||
| General and Administrative | 1,446,169.00 | -81,566,201.20 | -89,235,773.41 | -83,103,396.01 | 25,648,012.00 | 9,315,699.00 | 11,490,099.00 | ||||||||||||
| Selling, General & Admin... | 189,247,520.00 | 255,775,165.00 | 216,850,188.00 | 782,153,552.00 | 608,616,394.00 | 689,949,745.00 | 952,784,623.00 | ||||||||||||
| Selling & Marketing Exp... | 187,801,351.00 | 337,341,366.00 | 306,085,961.00 | 865,256,948.00 | 582,968,382.00 | 680,634,046.00 | 941,294,524.00 | ||||||||||||
| Depreciation and Amortiz... | 33,800,122.00 | 4,904,700.00 | 11,968,900.00 | 40,845,329.00 | 70,475,463.00 | 141,582,388.00 | 140,328,627.00 | ||||||||||||
| Other Expenses | 968,004.00 | 932,238.00 | -1,270,119.13 | 1,907,935.00 | -1,226,781.42 | -3,155,095.87 | 69,380,370.00 | ||||||||||||
| Total Operating Expenses | 265,512,297.00 | 320,844,628.00 | 369,091,556.00 | 1,003,859,806.00 | 793,886,959.00 | 855,961,586.00 | 1,113,273,463.00 | ||||||||||||
| Cost and Exponses | 353,366,265.00 | 447,717,760.00 | 530,097,551.00 | 1,261,799,004.00 | 1,014,647,687.00 | 1,073,413,072.00 | 1,400,371,204.00 | ||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-100,525,435.51
+0% |
299,801,824.00
-398% |
432,041,145.00
+44% |
1,074,089,707.00
+149% |
706,976,269.00
-34% |
592,633,934.00
-16% |
1,010,057,252.00
+70% |
||||||||||||
| Operating Income Ratio | (-0.35%) | (0.37%) | (0.41%) | (0.44%) | (0.39%) | (0.32%) | (0.42%) | ||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 505,441.00 | 1,408,207.00 | 1,776,107.00 | 5,390,093.00 | 5,057,662.00 | 16,411,272.00 | 11,435,817.00 | ||||||||||||
| Interest Expenses | 33,468.00 | 43,615.00 | 64,845.00 | 7,986,944.00 | 13,315,822.00 | 10,693,071.00 | 6,187,145.00 | ||||||||||||
| Total Other Income/Exp... | 19,258,768.00 | 1,548,131.00 | 33,453.00 | -35,652.00 | -1,226,782.00 | -3,155,095.00 | -3,176,136.00 | ||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 12,216,807.00 | 306,254,700.00 | 444,043,500.00 | 1,117,127,261.00 | 789,735,019.00 | 741,882,852.00 | 1,157,926,743.00 | ||||||||||||
| EBITDA ratio | (0.04%) | (0.56%) | (0.62%) | (0.50%) | (0.50%) | (0.52%) | (0.48%) | ||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -99,557,431.44 | 301,349,955.00 | 432,074,598.00 | 1,074,054,055.00 | 705,749,487.00 | 589,478,839.00 | 1,006,881,116.00 | ||||||||||||
| Income Before Tax Ratio | (-0.35%) | (0.38%) | (0.41%) | (0.44%) | (0.39%) | (0.32%) | (0.42%) | ||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | -22,675,854.69 | 31,202,137.00 | 56,776,879.00 | 149,144,925.00 | 84,777,072.00 | 69,844,034.00 | 146,912,518.00 | ||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | -76,881,576.75
+0% |
270,147,818.00
-451% |
375,297,719.00
+39% |
924,909,129.00
+146% |
620,972,414.00
-33% |
519,634,804.00
-16% |
859,968,598.00
+65% |
||||||||||||
| Net Income Ratio | (-0.27%) | (0.34%) | (0.36%) | (0.38%) | (0.34%) | (0.28%) | (0.36%) | ||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | -0.14 | 0.50 | 0.63 | 1.54 | 1.03 | 0.87 | 1.43 | ||||||||||||
| Diluted EPS | -0.14 | 0.50 | 0.63 | 1.54 | 1.03 | 0.87 | 1.43 | ||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 539,898,713.00 | 540,007,632.00 | 600,015,060.00 | 600,015,060.00 | 600,015,060.00 | 600,015,060.00 | 600,704,525.00 | ||||||||||||
| Diluted Share Outstanding | 539,898,713.00 | 540,007,632.00 | 600,015,060.00 | 600,015,060.00 | 600,015,060.00 | 600,015,060.00 | 602,429,841.00 | ||||||||||||